glp-1 effects on muscle mass Lean loss receptor agonists: a downside of the “miracle drugs” GLP-1 medications have changed the

1, 2026 upon plan anniversary: Fully Insured Non-Grandfathered Large Group Plans: Coverage for weight-loss drugs, including GLP-1s and oral medications, will be removed

The AMA also noted that health risks differ both between and within demographic groups, and that BMI cutoffs were based primarily on data collected from previous generations of non-Hispanic White populations and [do] not consider a persons gender or ethnicity. The United States had one of the highest adult obesity rates in the world as of 2016, the most recent year for which the World Health Organization (WHO) has comprehensive data

Her background is in clinical pharmacy, and now she's an obesity director at Novo Nordisk

You and your doctor should carefully weigh the benefits of oral GLP-1 medications against the potential risks